Cipher Pharmaceuticals Schedules Q2 2023 Earnings Release and Conference Call

MISSISSAUGA, ON, July 28, 2023 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced that it will release its financial results for the second quarter of 2023 on Thursday, August 10, 2023. The Company will also host a conference call on Friday, August 11, 2023 at 8:30am ET to discuss the results and corporate developments. 

CONFERENCE CALL DETAILS

DATE:	Friday, August 11, 2023
TIME:	8:30 a.m. ET
DIAL-IN NUMBER:	[phone] or [phone]
CONFERENCE ID:	71994934
REPLAY DIAL-IN:	[phone] (playback 959756#)
	Expires August 18, 2023
WEBCAST:	https://app.webinar.net/l8n1YB8qokM

About Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals (TSX: CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America. For more information, visit www.cipherpharma.com.

SOURCE Cipher Pharmaceuticals Inc.

James Bowen, CFA, Investor Relations - Cipher Pharmaceuticals, [email protected], [phone]